eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. (image: rex/shutterstock)
. to add a comment. registration is free, and takes less than a minute.
.
staff blog: medicine matters
.
.
.
when hard rains fall, the media are there with an umbrella to hold over organized society�s head. to walk away in the middle of a downpour would leave the status quo unprotected.
https://grassfed.us/Kempisty-grandpa-of-Klempa-from-Karbow
.
.